Transaction · 0001437749-26-029236

JORDEN DAVID EMERSON

JORDEN DAVID EMERSON, CEO, CFO, reported a transaction classified as grant at Nuo Therapeutics, Inc. involving 789.000000 shares for an estimated $844.23. Reported holdings after the transaction were 2062016.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACEO, CFO
AURXNuo Therapeutics, Inc.
Filing timeAug 29
Trade dateAug 27, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

AURX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
AURX since 2026-08-29Filed 5 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001437749-26-029236
Common Stock
Transaction date
Aug 27, 2026
Filed Aug 29, 2026, 01:46 AM · 2d delay
Shares
789 sh
$107 per share
Estimated value
$84.4k
Computed from shares × price
Holdings after
2.06M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO/CFO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.08 to $1.10, inclusive. The reporting person undertakes to pr…

Original filing · 0001437749-26-029236
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

AURX